Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trialJane C. Burns, Nichole Samuy, Kavita Sharma et al.|The Lancet Child & Adolescent Health|2021Cited by 113
Changes in serotype prevalence of Streptococcus pneumoniae in Southampton, UK between 2006 and 2018David Cleary, Stuart C. Clarke, Jessica Jones et al.|Scientific Reports|2022Cited by 49
The upper respiratory tract microbiome of indigenous Orang Asli in north-eastern Peninsular MalaysiaDavid Cleary, Stuart C. Clarke, Denise E. Morris et al.|npj Biofilms and Microbiomes|2021Cited by 40
The upper respiratory tract microbiome of indigenous Orang Asli in north-eastern Peninsular MalaysiaDavid Cleary, Stuart C. Clarke, Denise E. Morris et al.|medRxiv|2020Cited by 1